PROTEON THERAPEUTICS INC's ticker is PRTO and the CUSIP is 74371L109. A total of 45 filers reported holding PROTEON THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $73,000 | -29.1% | 47,200 | -20.0% | 0.00% | 0.0% |
| Q1 2017 | $103,000 | -8.0% | 58,986 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $112,000 | -79.6% | 58,986 | 0.0% | 0.00% | -87.5% |
| Q3 2016 | $550,000 | +85.8% | 58,986 | +60.1% | 0.01% | +60.0% |
| Q2 2016 | $296,000 | +221.7% | 36,835 | +211.2% | 0.01% | +150.0% |
| Q1 2016 | $92,000 | -50.0% | 11,835 | 0.0% | 0.00% | -33.3% |
| Q4 2015 | $184,000 | +11.5% | 11,835 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $165,000 | -21.8% | 11,835 | 0.0% | 0.00% | -25.0% |
| Q2 2015 | $211,000 | – | 11,835 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer VII & Co. Ltd. | 315,101 | $599,000 | 25.51% |
| Abingworth LLP | 2,017,872 | $3,632,000 | 3.04% |
| Pharmstandard International S.A. | 1,165,344 | $2,214,000 | 1.91% |
| MPM ASSET MANAGEMENT LLC | 983,381 | $1,868,000 | 0.88% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,332,599 | $2,532,000 | 0.10% |
| Perceptive Advisors | 334,116 | $635,000 | 0.04% |
| Baker Brothers Advisors | 389,394 | $740,000 | 0.01% |
| WEDBUSH SECURITIES INC | 17,000 | $32,000 | 0.01% |
| FINANCIAL COUNSELORS INC | 50,000 | $95,000 | 0.01% |
| PILLAR PACIFIC CAPITAL MANAGEMENT LLC | 11,499 | $21,000 | 0.00% |